Clinical Medicine
Listando 98 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
2771
Twitter
0
Wikipedia
4
News
0
Policy
Article
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
Pinato, David J.; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Liberti
CANCER DISCOVERY
2159-8274 (2020)
DOI /
10.1158/2159-8290.cd-20-0773
Green published, Bronze
Mentions
203
Twitter
0
Wikipedia
50
News
0
Policy
Article
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies
Prat, Aleix; Chaudhury, Anwesha; Solovieff, Nadia; Pare, Laia; Martinez, Debora; Chic, Nuria; Martinez-Saez, Olga; Braso-Maristany, Fara; Lteif, Agnes; Taran, Tetiana; Babbar, Naveen; Su, Fei
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.02977
Gold other
Mentions
48
Twitter
0
Wikipedia
60
News
0
Policy
Article
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30021-9
Mentions
78
Twitter
0
Wikipedia
37
News
0
Policy
Article
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer
Chic, Nuria; Luen, Stephen J.; Nuciforo, Paolo; Salgado, Roberto; Fumagalli, Debora; Hilbers, Florentine; Wang, Yingbo; de Azambuja, Evandro; Lang, Istvan; Di Cosimo, Serena; Saura, Cristina; Huober, Jens; Prat, Aleix; Loi, Sherene
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2021)
DOI /
10.1093/jnci/djab057
Mentions
73
Twitter
0
Wikipedia
37
News
0
Policy
Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx647
Bronze
Mentions
137
Twitter
0
Wikipedia
183
News
0
Policy
Editorial Material
Current and Future Management of HER2-Positive Metastatic Breast Cancer
Martinez-Saez, Olga; Prat, Aleix
JCO ONCOLOGY PRACTICE
2688-1527 (2021)
DOI /
10.1200/op.21.00172
Bronze
Mentions
18
Twitter
0
Wikipedia
27
News
0
Policy
Article
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Puig, Isabel; Tenbaum, Stephan P.; Chicote, Irene; Arques, Oriol; Martinez-Quintanilla, Jordi; Cuesta-Borras, Estefania; Ramirez, Lorena; Gonzalo, Pilar; Soto, Atenea; Aguilar, Susana; Eguizabal, Cristina; Caratu, Ginevra; Prat, Aleix; Argiles, Guillem; La
JOURNAL OF CLINICAL INVESTIGATION
0021-9738 (2018)
DOI /
10.1172/jci96393
Bronze, Green published
Mentions
193
Twitter
0
Wikipedia
9
News
0
Policy
Article
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer,
LANCET ONCOLOGY
1470-2045 (2020)
DOI /
10.1016/s1470-2045(19)30786-7
Mentions
192
Twitter
0
Wikipedia
9
News
0
Policy
Article
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Ju
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-020-00208-2
Green published, Gold
Mentions
279
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, Manuel; Brahmer, Julie R.; Callahan, Margaret K.; Flores-Chavez, Alejandro; Keegan, Niamh; Khamashta, Munther A.; Lambotte, Olivier; Marlette, Xavier; Prat, Aleix; Suarez-Almazor, Maria E.
NATURE REVIEWS DISEASE PRIMERS
2056-676X (2020)
DOI /
10.1038/s41572-020-0160-6
Mentions
186
Twitter
0
Wikipedia
2
News
0
Policy
Review
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
Giuliano, Mario; Schettini, Francesco; Rognoni, Carla; Milani, Manuela; Jerusalem, Guy; Bachelot, Thomas; De Laurentiis, Michelino; Thomas, Guglielmo; De Placido, Pietro; Arpino, Grazia; De Placido, Sabino; Cristofanilli, Massimo; Giordano, Antonio; Puglis
LANCET ONCOLOGY
1470-2045 (2019)
DOI /
10.1016/s1470-2045(19)30420-6
Green published
Mentions
231
Twitter
0
Wikipedia
0
News
0
Policy
Article
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-0844
Mentions
50
Twitter
0
Wikipedia
5
News
0
Policy
Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria;
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2020)
DOI /
10.1093/jnci/djz042
Green published, Bronze
Mentions
106
Twitter
0
Wikipedia
1
News
0
Policy
Article
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
Rugo, Hope S.; Lerebours, Florence; Ciruelos, Eva; Drullinsky, Pamela; Ruiz-Borrego, Manuel; Neven, Patrick; Park, Yeon Hee; Prat, Aleix; Bachelot, Thomas; Juric, Dejan; Turner, Nicholas; Sophos, Nickolas; Zarate, Juan Pablo; Arce, Christina; Shen, Yu-ming
LANCET ONCOLOGY
1470-2045 (2021)
DOI /
10.1016/s1470-2045(21)00034-6
Mentions
80
Twitter
0
Wikipedia
1
News
0
Policy
Article
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
Duruisseaux, Michael; Martinez-Cardus, Anna; Calleja-Cervantes, Maria E.; Moran, Sebastian; Castro de Moura, Manuel; Davalos, Veronica; Pineyro, David; Sanchez-Cespedes, Montse; Girard, Nicolas; Brevet, Marie; Giroux-Leprieur, Etienne; Dumenil, Coraline; P
LANCET RESPIRATORY MEDICINE
2213-2600 (2018)
DOI /
10.1016/s2213-2600(18)30284-4
Green accepted
Mentions
51
Twitter
0
Wikipedia
7
News
0
Policy
Article
Chemotherapy de-escalation using an F-18-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
Manuel Perez-Garcia, Jose; Gebhart, Geraldine; Ruiz Borrego, Manuel; Stradella, Agostina; Bermejo, Begona; Schmid, Peter; Marme, Frederik; Escriva-de-Romani, Santiago; Calvo, Lourdes; Ribelles, Nuria; Martinez, Noelia; Albacar, Cinta; Prat, Aleix; Dalenc,
LANCET ONCOLOGY
1470-2045 (2021)
DOI /
10.1016/s1470-2045(21)00122-4
Mentions
155
Twitter
0
Wikipedia
0
News
0
Policy
Article
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Garcia-Recio, Susana; Thennavan, Aatish; East, Michael P.; Parker, Joel S.; Cejalvo, Juan M.; Garay, Joseph P.; Hollern, Daniel P.; He, Xiaping; Mott, Kevin R.; Galvan, Patricia; Fan, Cheng; Selitsky, Sara R.; Coffey, Alisha R.; Marron, David; Braso-Marist
JOURNAL OF CLINICAL INVESTIGATION
0021-9738 (2020)
DOI /
10.1172/jci130323
Bronze, Green published
Mentions
125
Twitter
0
Wikipedia
0
News
0
Policy
Article
Gene expression profiles of breast cancer metastasis according to organ site
Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa
MOLECULAR ONCOLOGY
1574-7891 (2021)
DOI /
10.1002/1878-0261.13021
Gold DOAJ
Mentions
73
Twitter
0
Wikipedia
2
News
0
Policy
Article
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Prat, Aleix; Navarro, Alejandro; Pare, Laia; Reguart, Noemi; Galvan, Patricia; Pascual, Tomas; Martinez, Alex; Nuciforo, Paolo; Comerma, Laura; Alos, Llucia; Pardo, Nuria; Cedres, Susana; Fan, Cheng; Parker, Joel S.; Gaba, Lydia; Victoria, Ivan; Vinolas, N
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-3556
Bronze
Mentions
26
Twitter
0
Wikipedia
4
News
0
Policy
Article
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+breast cancer
Veeraraghavan, J.; De Angelis, C.; Mao, R.; Wang, T.; Herrera, S.; Pavlick, A. C.; Contreras, A.; Nuciforo, P.; Mayer, I. A.; Forero, A.; Nanda, R.; Goetz, M. P.; Chang, J. C.; Wolff, A. C.; Krop, I. E.; Fuqua, S. A. W.; Prat, A.; Hilsenbeck, S. G.; Weigel
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdz076
Gold other, Green published
Mentions
10
Twitter
0
Wikipedia
6
News
0
Policy
Article
Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity
Gomez-Miragaya, Jorge; Diaz-Navarro, Ander; Tonda, Raul; Beltran, Sergi; Palomero, Luis; Palafox, Marta; Dobrolecki, Lacey E.; Huang, Chen; Vasaikar, Suhas; Zhang, Bing; Wulf, Gerburg M.; Collado-Sole, Alejandro; Trinidad, Eva M.; Munoz, Purificacion; Pare
CANCER RESEARCH
0008-5472 (2019)
DOI /
10.1158/0008-5472.can-18-3835
Bronze
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy335
Bronze
Mentions
109
Twitter
0
Wikipedia
0
News
0
Policy
Article
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy
Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin
EBIOMEDICINE
2352-3964 (2021)
DOI /
10.1016/j.ebiom.2021.103451
Green published, Gold
Mentions
85
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael
NATURE COMMUNICATIONS
(2020)
DOI /
10.1038/s41467-019-14111-3
Gold DOAJ, Green published
Mentions
31
Twitter
0
Wikipedia
3
News
0
Policy
Article
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models
Gomez-Miragaya, Jorge; Moran, Sebastian; Erendira Calleja-Cervantes, Maria; Collado-Sole, Alejandro; Pare, Laia; Gomez, Antonio; Serra, Violeta; Dobrolecki, Lacey E.; Lewis, Michael T.; Diaz-Lagares, Angel; Eroles, Pilar; Prat, Aleix; Esteller, Manel; Gonz
MOLECULAR CANCER RESEARCH
1541-7786 (2019)
DOI /
10.1158/1541-7786.mcr-19-0040
Bronze, Green accepted
Mentions
81
Twitter
0
Wikipedia
0
News
0
Policy
Article
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Anna Belen; Schettini, Francesco; Conte, Benedetta; Vidal, Maria; Adamo, Bar
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00218-8
Gold DOAJ, Green published
Mentions
50
Twitter
0
Wikipedia
1
News
0
Policy
Review
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
Schettini, Francesco; Pascual, Tomas; Conte, Benedetta; Chic, Nuria; Braso-Maristany, Fara; Galvan, Patricia; Martinez, Olga; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Fernandez-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina
CANCER TREATMENT REVIEWS
0305-7372 (2020)
DOI /
10.1016/j.ctrv.2020.101965
Mentions
23
Twitter
0
Wikipedia
3
News
0
Policy
Article
SEOM clinical guidelines in early stage breast cancer (2018)
Ayala de la Pena, F.; Andres, R.; Garcia-Saenz, J. A.; Manso, L.; Margeli, M.; Dalmau, E.; Pernas, S.; Prat, A.; Servitja, S.; Ciruelos, E.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2019)
DOI /
10.1007/s12094-018-1973-6
Green published, Gold other
Mentions
73
Twitter
0
Wikipedia
1
News
0
Policy
Article
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer
Prat, Aleix; Tsai, Yi-Hsuan; Pascual, Tomas; Pare, Laia; Adamo, Barbara; Vidal, Maria; Braso-Maristany, Fara; Galvan, Patricia; Brase, Jan Christoph; Rodrik-Outmezguine, Vanessa; Johnston, Stephen; Ciruelos, Eva; Parker, Joel S.
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-2793
Mentions
87
Twitter
0
Wikipedia
0
News
0
Policy
Article
ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galv
CANCERS
(2020)
DOI /
10.3390/cancers12071902
Gold DOAJ, Green published
Mentions
27
Twitter
0
Wikipedia
2
News
0
Policy
Article
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer
Cejalvo, Juan M.; de Duenas, Eduardo Martinez; Galvan, Patricia; Garcia-Recio, Susana; Gasion, Octavio Burgues; Pare, Laia; Antolin, Silvia; Martinello, Rosella; Blancas, Isabel; Adamo, Barbara; Guerrero-Zotano, Angel; Munoz, Montserrat; Nuciforow, Paolo;
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-2717
Bronze, Green accepted
Mentions
64
Twitter
0
Wikipedia
0
News
0
Policy
Article
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Martinez-Saez, Olga; Chic, Nuria; Pascual, Tomas; Adamo, Barbara; Vidal, Maria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Braso-Maristany, Fara; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Ana Be
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01284-9
Gold DOAJ, Green published
Mentions
49
Twitter
0
Wikipedia
0
News
0
Policy
Article
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis
Pascual, Tomas; Gonzalez-Farre, Blanca; Teixido, Cristina; Oleaga, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Nuria; Riu, Gisela; Adamo, Barbara; Galvan, Patricia; Vidal, Maria; Soy, Dolors; Urbano, Alvaro; Munoz, Monserrat; Prat, Aleix
JCO PRECISION ONCOLOGY
(2019)
DOI /
10.1200/po.19.00012
Mentions
55
Twitter
0
Wikipedia
0
News
0
Policy
Article
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
Adamo, Barbara; Bellet, Meritxell; Pare, Laia; Pascual, Tomas; Vidal, Maria; Perez Fidalgo, Jose A.; Blanch, Salvador; Martinez, Noelia; Murillo, Laura; Gomez-Pardo, Patricia; Lopez-Gonzalez, Ana; Amillano, Kepa; Canes, Jordi; Galvan, Patricia; Gonzalez-Fa
BREAST CANCER RESEARCH
1465-542X (2019)
DOI /
10.1186/s13058-019-1195-z
Gold DOAJ, Green published
Mentions
46
Twitter
0
Wikipedia
0
News
0
Policy
Review
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer
Miguel Cejalvo, Juan; Pascual, Tomas; Fernandez-Martinez, Aranzazu; Braso-Maristany, Fara; Gomis, Roger R.; Perou, Charles M.; Munoz, Montserrat; Prat, Aleix
CANCER TREATMENT REVIEWS
0305-7372 (2018)
DOI /
10.1016/j.ctrv.2018.04.015
Gold other
Mentions
66
Twitter
0
Wikipedia
0
News
0
Policy
Article
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2(+) Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
Guarneri, Valentina; Dieci, Maria Vittoria; Bisagni, Giancarlo; Brandes, Alba A.; Frassoldati, Antonio; Cavanna, Luigi; Musolino, Antonino; Giotta, Francesco; Rimanti, Anita; Garrone, Ornella; Bertone, Elena; Cagossi, Katia; Nanni, Oriana; Piacentini, Fede
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-1731
Bronze, Green published
Mentions
61
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz,
FRONTIERS IN ONCOLOGY
2234-943X (2021)
DOI /
10.3389/fonc.2021.638482
Gold DOAJ, Green published
Mentions
43
Twitter
0
Wikipedia
0
News
0
Policy
Article
Dissecting the biological heterogeneity of HER2-positive breast cancer
Schettini, Francesco; Prat, Aleix
BREAST
0960-9776 (2021)
DOI /
10.1016/j.breast.2021.07.019
Green published, Gold
Mentions
36
Twitter
0
Wikipedia
1
News
0
Policy
Review
Third-line treatment of HER2-positive advanced breast cancer: From no standard to a Pandora's box
Tarantino, Paolo; Prat, Aleix; Cortes, Javier; Cardoso, Fatima; Curigliano, Giuseppe
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
0304-419X (2021)
DOI /
10.1016/j.bbcan.2020.188487
Mentions
51
Twitter
0
Wikipedia
0
News
0
Policy
Article
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-20-4102
Bronze
Mentions
46
Twitter
0
Wikipedia
0
News
0
Policy
Review
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
Griguolo, Gaia; Pascual, Tomas; Dieci, Maria Vittoria; Guarneri, Valentina; Prat, Aleix
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2019)
DOI /
10.1186/s40425-019-0548-6
Gold DOAJ, Green published
Mentions
47
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer
Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal
FUTURE ONCOLOGY
1479-6694 (2020)
DOI /
10.2217/fon-2020-0246
Mentions
50
Twitter
0
Wikipedia
0
News
0
Policy
Article
What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?
Brandao, Mariana; Caparica, Rafael; Malorni, Luca; Prat, Aleix; Carey, Lisa A.; Piccart, Martine
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-19-2612
Mentions
39
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor
BMC MEDICINE
1741-7015 (2019)
DOI /
10.1186/s12916-018-1233-1
Green published, Gold
Mentions
41
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, A
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00351-4
Gold
Mentions
37
Twitter
0
Wikipedia
0
News
0
Policy
Article
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts
Gris-Oliver, Albert; Palafox, Marta; Monserrat, Laia; Braso-Maristany, Fara; Odena, Andreu; Sanchez-Guixe, Monica; Ibrahim, Yasir H.; Villacampa, Guillermo; Grueso, Judit; Pars, Mireia; Guzman, Marta; Rodriguez, Olga; Bruna, Alejandra; Hirst, Caroline S.;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-19-3324
Bronze, Green accepted
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Frigola, Joan; Navarro, Alejandro; Carbonell, Caterina; Callejo, Ana; Iranzo, Patricia; Cedres, Susana; Martinez-Marti, Alex; Pardo, Nuria; Saoudi-Gonzalez, Nadia; Martinez, Debora; Jimenez, Jose; Sansano, Irene; Mancuso, Francesco M.; Nuciforo, Paolo; Mon
MOLECULAR ONCOLOGY
1574-7891 (2021)
DOI /
10.1002/1878-0261.12891
Gold DOAJ, Green published
Mentions
44
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro
FRONTIERS IN ONCOLOGY
2234-943X (2019)
DOI /
10.3389/fonc.2019.00303
Gold DOAJ, Green published
Mentions
42
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Sharma, Priyanka; Lopez-Tarruella, Sara; Angel Garcia-Saenz, Jose; Khan, Qamar J.; Gomez, Henry L.; Prat, Aleix; Moreno, Fernando; Jerez-Gilarranz, Yolanda; Barnadas, Agusti; Picornell, Antoni C.; del Monte-Millan, Maria; Gonzalez-Rivera, Milagros; Massarr
CLINICAL CANCER RESEARCH
1078-0432 (2018)
DOI /
10.1158/1078-0432.ccr-18-0585
Bronze, Green accepted
Mentions
34
Twitter
0
Wikipedia
0
News
0
Policy
Article
Predictive model of complexity in early palliative care: a cohort of advanced cancer patients (PALCOM study)
Tuca, Albert; Gomez-Martinez, Monica; Prat, Aleix
SUPPORTIVE CARE IN CANCER
0941-4355 (2018)
DOI /
10.1007/s00520-017-3840-3
Mentions
16
Twitter
0
Wikipedia
1
News
0
Policy
Article
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
Marin, Elba; Teixido, Cristina; Carmona-Rocha, Elena; Reyes, Roxana; Arcocha, Ainara; Vinolas, Nuria; Rodriguez-Mues, MCarmen; Cabrera, Carlos; Sanchez, Marcelo; Vollmer, Ivan; Castillo, Sergi; Munoz, Silvia; Sullivan, Ivana G.; Rodriguez, Adela; Garcia, M
CANCERS
(2020)
DOI /
10.3390/cancers12051124
Gold, Green published
Mentions
17
Twitter
0
Wikipedia
1
News
0
Policy
Article
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
Pinato, David J.; Lee, Alvin J. X.; Biello, Federica; Segui, Elia; Aguilar-Company, Juan; Carbo, Anna; Bruna, Riccardo; Bower, Mark; Rizzo, Gianpiero; Benafif, Sarah; Carmona, Carme; Chopra, Neha; Cruz, Claudia Andrea; D'Avanzo, Francesca; Evans, Joanne S.
CANCERS
(2020)
DOI /
10.3390/cancers12071841
Green published, Gold
Mentions
31
Twitter
0
Wikipedia
0
News
0
Policy
Review
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Schettini, Francesco; Giudici, Fabiola; Giuliano, Mario; Cristofanilli, Massimo; Arpino, Grazia; Del Mastro, Lucia; Puglisi, Fabio; De Placido, Sabino; Paris, Ida; De Placido, Pietro; Venturini, Sergio; de Laurentis, Michelino; Conte, Pierfranco; Juric, De
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2020)
DOI /
10.1093/jnci/djaa071
Green published
Mentions
36
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon,
NPJ PRECISION ONCOLOGY
(2021)
DOI /
10.1038/s41698-021-00163-6
Gold DOAJ
Mentions
31
Twitter
0
Wikipedia
0
News
0
Policy
Article
De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Guarneri, V; Dieci, M., V; Bisagni, G.; Frassoldati, A.; Bianchi, G., V; De Salvo, G. L.; Orvieto, E.; Urso, L.; Pascual, T.; Pare, L.; Galvan, P.; Ambroggi, M.; Giorgi, C. A.; Moretti, G.; Griguolo, G.; Vicini, R.; Prat, A.; Conte, P. F.
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdz055
Gold other, Green published
Mentions
28
Twitter
0
Wikipedia
0
News
0
Policy
Review
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Schettini, Francesco; Giuliano, Mario; Giudici, Fabiola; Conte, Benedetta; De Placido, Pietro; Venturini, Sergio; Rognoni, Carla; Di Leo, Angelo; Locci, Mariavittoria; Jerusalem, Guy; Del Mastro, Lucia; Puglisi, Fabio; Conte, Pierfranco; De Laurentiis, Mic
CANCERS
(2021)
DOI /
10.3390/cancers13061458
Gold DOAJ, Green published
Mentions
33
Twitter
0
Wikipedia
0
News
0
Policy
Article
Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer
Schettini, F.; Barbao, P.; Braso-Maristany, F.; Galvan, P.; Martinez, D.; Pare, L.; De Placido, S.; Prat, A.; Guedan, S.
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100102
Green published, Gold
Mentions
27
Twitter
0
Wikipedia
0
News
0
Policy
Article
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
De Mattos-Arruda, Leticia; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel G.; Villacampa, Guillermo; Goncalves-Ribeiro, Samuel; Pare, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John; Cusco, Pol; Fasani, Roberta; Chin, Suet-Feung; Perez
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00282-0
Green published, Gold
Mentions
24
Twitter
0
Wikipedia
0
News
0
Policy
Article
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer
Aguado, Cristina; Teixido, Cristina; Roman, Ruth; Reyes, Roxana; Gimenez-Capitan, Ana; Marin, Elba; Cabrera, Carlos; Vinolas, Nuria; Castillo, Sergi; Munoz, Silvia; Arcocha, Ainara; Lopez-Vilaro, Laura; Sullivan, Ivana; Aldeguer, Erika; Rodriguez, Sonia; M
MOLECULAR ONCOLOGY
1574-7891 (2020)
DOI /
10.1002/1878-0261.12861
Gold DOAJ, Green published
Mentions
19
Twitter
0
Wikipedia
0
News
0
Policy
Article
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
Braso-Maristany, Fara; Sanso, Miriam; Chic, Nuria; Martinez, Debora; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Ghiglione, Lucio; Carcelero, Esther; Garcia-Corbacho, Javier; Sanchez, Marcelo; Soy, Dolors; Jares, Pedro; Peg, Vicente; Saura, Cristina; Munoz,
FRONTIERS IN ONCOLOGY
2234-943X (2021)
DOI /
10.3389/fonc.2021.710596
Green published, Gold
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy
Floros, Konstantinos V.; Lochmann, Timothy L.; Hu, Bin; Monterrubio, Carles; Hughes, Mark T.; Wells, Jason D.; Bernado Morales, Cristina; Ghotra, Maninderjit S.; Costa, Carlotta; Souers, Andrew J.; Boikos, Sosipatros A.; Leverson, Joel D.; Tan, Ming; Serra
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
0027-8424 (2018)
DOI /
10.1073/pnas.1717820115
Gold other, Green published
Mentions
8
Twitter
0
Wikipedia
1
News
1
Policy
Article
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Sharma, Priyanka; Lopez-Tarruella, Sara; Angel Garcia-Saenz, Jose; Ward, Claire; Connor, Carol S.; Gomez, Henry L.; Prat, Aleix; Moreno, Fernando; Jerez-Gilarranz, Yolanda; Barnadas, Augusti; Picornell, Antoni C.; del Monte-Millan, Maria; Gonzalez-Rivera,
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-0162
Green accepted, Bronze
Mentions
23
Twitter
0
Wikipedia
0
News
0
Policy
Article
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx(R) Digital Spatial Profiler
Bergholtz, Helga; Carter, Jodi M.; Cesano, Alessandra; Cheang, Maggie Chon U.; Church, Sarah E.; Divakar, Prajan; Fuhrman, Christopher A.; Goel, Shom; Gong, Jingjing; Guerriero, Jennifer L.; Hoang, Margaret L.; Hwang, E. Shelley; Kuasne, Hellen; Lee, Jinho
CANCERS
(2021)
DOI /
10.3390/cancers13174456
Green published, Gold
Mentions
45
Twitter
0
Wikipedia
0
News
0
Policy
Article
The BRCA1 Pseudogene Negatively Regulates Antitumor Responses through Inhibition of Innate Immune Defense Mechanisms
Han, Yoo Jane; Zhang, Jing; Lee, Jung-hyun; Mason, Jennifer M.; Karginova, Olga; Yoshimatsu, Toshio F.; Hao, Qinyu; Hurley, Ian; Brunet, Laia Pare; Prat, Aleix; Prasanth, Kannanganattu, V; Gack, Michaela U.; Olopade, Olufunmilayo, I
CANCER RESEARCH
0008-5472 (2021)
DOI /
10.1158/0008-5472.can-20-1959
Mentions
23
Twitter
0
Wikipedia
0
News
0
Policy
Review
Biomarkers of immunotherapy response in breast cancer beyond PD-L1
Chic, Nuria; Braso-Maristany, Fara; Prat, Aleix
BREAST CANCER RESEARCH AND TREATMENT
0167-6806 (2021)
DOI /
10.1007/s10549-021-06421-2
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2
Prat, Aleix; Christoph Brase, Jan; Cheng, Yuan; Nuciforo, Paolo; Pare, Laia; Pascual, Tomas; Martinez, Debora; Galvan, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, Jose; Ciruelos, Eva
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0407
Green published, Bronze
Mentions
23
Twitter
0
Wikipedia
0
News
0
Policy
Article
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Soosaipillai, Gehan; Wu, Anjui; Dettorre, Gino M.; Diamantis, Nikolaos; Chester, John; Moss, Charlotte; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Brunet, Joan; Jones, Eleanor; Mesia, Ricard; Jackson, Amanda; Mukherjee, Uma
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
1758-8340 (2021)
DOI /
10.1177/17588359211042224
Green published, Gold
Mentions
19
Twitter
0
Wikipedia
0
News
0
Policy
Article
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data
Diaz-Redondo, Tamara; Lavado-Valenzuela, Rocio; Jimenez, Begona; Pascual, Tomas; Galvez, Fernando; Falcon, Alejandro; Alamo, Maria del Carmen; Morales, Cristina; Amerigo, Marta; Pascual, Javier; Sanchez-Munoz, Alfonso; Gonzalez-Guerrero, Macarena; Vicioso,
FRONTIERS IN ONCOLOGY
2234-943X (2019)
DOI /
10.3389/fonc.2019.01178
Gold DOAJ, Green published
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy
De Angelis, Carmine; Nagi, Chandandeep; Hoyt, Cliff C.; Liu, Linying; Roman, Kristin; Wang, Chichung; Zheng, Yi; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Nuciforo, Paolo; Wang, Tao; Tsimelzon, Anna; Mao, Sufeng; Hilsenbeck, Susan G.; Trivedi, Me
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-19-1402
Green accepted
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial
Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claud
INTERNATIONAL JOURNAL OF CANCER
0020-7136 (2020)
DOI /
10.1002/ijc.32488
Mentions
12
Twitter
0
Wikipedia
0
News
0
Policy
Article
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
Jimenez, Natalia; Reig, Oscar; Montalbo, Ruth; Mila-Guasch, Maria; Nadal-Dieste, Lluis; Castellano, Giancarlo; Jose Lozano, Juan; Victoria, Ivan; Font, Albert; Rodriguez-Vida, Alejo; Carles, Joan; Suarez, Cristina; Domenech, Montserrat; Sala-Gonzalez, Nuri
FRONTIERS IN ONCOLOGY
2234-943X (2020)
DOI /
10.3389/fonc.2020.594023
Gold DOAJ, Green published
Mentions
12
Twitter
0
Wikipedia
0
News
0
Policy
Article
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer
Marin-Aguilera, Mercedes; Reig, Oscar; Mila-Guasch, Maria; Font, Albert; Domenech, Montserrat; Rodriguez-Vida, Alejo; Carles, Joan; Suarez, Cristina; Gonzalez del Alba, Aranzazu; Jimenez, Natalia; Victoria, Ivan; Sala-Gonzalez, Nuria; Jose Ribal, Maria; Lo
INTERNATIONAL JOURNAL OF CANCER
0020-7136 (2019)
DOI /
10.1002/ijc.32238
Mentions
17
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Standardized versus research-based PAM50 intrinsic subtyping of breast cancer
Prat, A.; Parker, J. S.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-019-02203-x
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Review
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Schettini, Francesco; Giudici, Fabiola; Bernocchi, Ottavia; Sirico, Marianna; Corona, Silvia P.; Giuliano, Mario; Locci, Mariavittoria; Paris, Ida; Scambia, Giovanni; De Placido, Sabino; Rescigno, Pasquale; Prat, Aleix; Curigliano, Giuseppe; Generali, Dani
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.02.035
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway
Samaeekia, Ravand; Adorno-Cruz, Valery; Bockhorn, Jessica; Chang, Ya-Fang; Huang, Simo; Prat, Aleix; Ha, Nahun; Kibria, Golam; Huo, Dezheng; Zheng, Hui; Dalton, Rachel; Wang, Yuhao; Moskalenko, Grigoriy Y.; Liu, Huiping
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-0943
Bronze, Green accepted
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Article
Original Research Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial
Guarneri, Valentina; V. Dieci, Maria; Griguolo, Gaia; Miglietta, Federica; Girardi, Fabio; Bisagni, Giancarlo; Generali, Daniele G.; Cagossi, Katia; Sarti, Samanta; Frassoldati, Antonio; Gianni, Lorenzo; Cavanna, Luigi; Pinotti, Graziella; Musolino, Antoni
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.05.018
Hybrid, Green accepted, Green published
Mentions
17
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
Mayer, Ingrid A.; Prat, Aleix; Egle, Daniel; Blau, Sibel; Perez Fidalgo, J. Alejandro; Gnant, Michael; Fasching, Peter A.; Colleoni, Marco; Wolff, Antonio C.; Winer, Eric P.; Singer, Christian F.; Hurvitz, Sara; Garcia Estevez, Laura; van Dam, Peter A.; Ku
CLINICAL CANCER RESEARCH
1078-0432 (2019)
DOI /
10.1158/1078-0432.ccr-18-3160
Green accepted, Bronze
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, Ana C.; Saura, Cristina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begona; Gavila, Joaquin; Serra, Violeta; Prat, Aleix; Pare, Laia; Celiz, Pamela; Villagrasa, Patricia; Li, Yisheng; Savoie, Jennifer; Xu, Zhan; Arteaga, Car
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01354-y
Gold DOAJ, Green published
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Article
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial
Lambertini, Matteo; Campbell, Christine; Gelber, Richard D.; Viale, Giuseppe; McCullough, Ann; Hilbers, Florentine; Korde, Larissa A.; Werner, Olena; Chumsri, Saranya; Jackisch, Christian; Wolff, Antonio C.; Vaz-Luis, Ines; Ferreira, Arlindo R.; Prat, Alei
BREAST CANCER RESEARCH AND TREATMENT
0167-6806 (2019)
DOI /
10.1007/s10549-019-05284-y
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pembrolizumab plus eribulin in hormone receptore-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trial
Perez-Garcia, Jose M.; Llombart-Cussac, Antonio; Cortes, Maria G.; Curigliano, Giuseppe; Lopez-Miranda, Elena; Alonso, Jose L.; Bermejo, Begona; Calvo, Lourdes; Caranana, Vicente; de la Cruz Sanchez, Susana; Vazquez, Raul M.; Prat, Aleix; Borrego, Manuel R
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.02.028
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
Sanz-Moreno, Adrian; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomas; Galvan, Patricia; Benitez, Sandra; Gomez-Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sonia; Petit, Anna; Soler-Monso, Maria Teresa; Vinas, Gemma; Alsaleem
BREAST CANCER RESEARCH
1465-542X (2021)
DOI /
10.1186/s13058-021-01390-2
Green published, Gold
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients
Reguart, Noemi; Teixido, Cristina; Gimenez-Capitan, Ana; Pare, Laia; Galvan, Patricia; Viteri, Santiago; Rodriguez, Sonia; Peg, Vicente; Aldeguer, Erika; Vinolas, Nuria; Remon, Jordi; Karachaliou, Niki; Conde, Esther; Lopez-Rios, Fernando; Nadal, Ernest; M
CLINICAL CHEMISTRY
0009-9147 (2017)
DOI /
10.1373/clinchem.2016.265314
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse
Prat, Aleix; Lluch, Ana; Turnbull, Arran K.; Dunbier, Anita K.; Calvo, Lourdes; Albanell, Joan; de la Haba-Rodriguez, Juan; Arcusa, Angels; Ignacio Chacon, Jose; Sanchez-Rovira, Pedro; Plazaola, Arrate; Munoz, Montserrat; Pare, Laia; Parker, Joel S.; Ribel
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-2092
Bronze, Green accepted, Green published
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Codony-Servat, Jordi; Cuatrecasas, Miriam; Asensio, Elena; Montironi, Carla; Martinez-Cardus, Anna; Marin-Aguilera, Mercedes; Horndler, Carlos; Martinez-Balibrea, Eva; Rubini, Michele; Jares, Pedro; Reig, Oscar; Victoria, Ivan; Gaba, Lydia; Martin-Richard,
BRITISH JOURNAL OF CANCER
0007-0920 (2017)
DOI /
10.1038/bjc.2017.279
Gold other, Green published
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Lozano, Ester; Mena, Mari-Pau; Diaz, Tania; Martin-Antonio, Beatriz; Leon, Sheila; Rodriguez-Lobato, Luis-Gerardo; Oliver-Caldes, Aina; Teresa Cibeira, Maria; Blade, Joan; Prat, Aleix; Rosinol, Laura; Fernandez de Larrea, Carlos
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-19-3673
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Development and validation for research assessment of Oncotype DX (R) Breast Recurrence Score, EndoPredict (R) and Prosigna (R)
Buus, Richard; Szijgyarto, Zsolt; Schuster, Eugene F.; Xiao, Hui; Haynes, Ben P.; Sestak, Ivana; Cuzick, Jack; Pare, Laia; Segui, Elia; Chic, Nuria; Prat, Aleix; Dowsett, Mitch; Cheang, Maggie Chon U.
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00216-w
Gold DOAJ, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Vasculitic neuropathy induced by pembrolizumab
Aya, F.; Ruiz-Esquide, V.; Viladot, M.; Font, C.; Prieto-Gonzalez, S.; Prat, A.; Arance, A.
ANNALS OF ONCOLOGY
0923-7534 (2017)
DOI /
10.1093/annonc/mdw613
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
Quintana, Angela; Peg, Vicente; Prat, Aleix; Moline, Teresa; Villacampa, Guillermo; Pare, Laia; Galvan, Patricia; Dientsmann, Rodrigo; Schmid, Peter; Curigliano, Giuseppe; Munoz-Couselo, Eva; Perez-Garcia, Jose; Marti, Merce; Blanco-Heredia, Juan; Dos Anjo
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.01.037
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
Diaz-Gil, Laura; Braso-Maristany, Fara; Locatelli, Claudriana; Centa, Ariana; Gyorffy, Balasz; Ocana, Alberto; Prat, Aleix; Pandiella, Atanasio
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
DOI /
10.1186/s13046-021-02098-z
Green published, Gold
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, Ignacio; Moreno, David F.; Moga, Esther; Mena, Mari-Pau; Tovar, Natalia; Gerardo Rodriguez-Lobato, Luis; Oliver-Caldes, Aina; Carmen Salgado, M.; Braso-Maristany, Fara; Yague, Jordi; Teresa Cibeira, M.; Prat, Aleix; Rosinol, Laura; Blade, Joan; Fern
ANNALS OF HEMATOLOGY
0939-5555 (2021)
DOI /
10.1007/s00277-021-04653-2
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver
Hruschka, Natascha; Kalisz, Mark; Subijana, Maria; Grana-Castro, Osvaldo; Del Cano-Ochoa, Francisco; Brunet, Laia Pare; Chernukhin, Igor; Sagrera, Ana; de Reynies, Aurelien; Kloesch, Bernhard; Chin, Suet-Feung; Burgues, Octavio; Andreu, David; Bermejo, Beg
ONCOGENE
0950-9232 (2020)
DOI /
10.1038/s41388-020-1376-3
Green published, Gold other
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Pertuzumab Use in the Adjuvant Setting: Why Not?
Prat, Aleix
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2017)
DOI /
10.1200/jco.2016.68.6212
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
Griguolo, Gaia; Dieci, Maria Vittoria; Pare, Laia; Miglietta, Federica; Generali, Daniele Giulio; Frassoldati, Antonio; Cavanna, Luigi; Bisagni, Giancarlo; Piacentini, Federico; Tagliafico, Enrico; Cagossi, Katia; Ficarra, Guido; Prat, Aleix; Conte, Pierfr
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00223-x
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo
ONCOTARGET
1949-2553 (2017)
DOI /
10.18632/oncotarget.15748
Bronze, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
Lluch, Ana; Gonzalez-Angulo, Ana M.; Casadevall, David; Eterovic, Agda K.; Martinez de Duenas, Eduardo; Zheng, Xiaofeng; Guerrero-Zotano, Angel; Liu, Shuying; Perez, Ramon; Chen, Ken; Ignacio Chacon, Jose; Mills, Gordon B.; Antolin, Silvia; Blancas, Isabel
EUROPEAN JOURNAL OF CANCER
0959-8049 (2019)
DOI /
10.1016/j.ejca.2019.07.003
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Molecular Tumor Boards
Rody, Achim; Ettl, Johannes; Marme, Frederik; Prat, Aleix
BREAST CARE
1661-3791 (2018)
DOI /
10.1159/000489138
Green published, Bronze
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes
Marin-Aguilera, Mercedes; Pereira, Maria V.; Jimenez, Natalia; Reig, Oscar; Cuartero, Anna; Victoria, Ivan; Aversa, Caterina; Ferrer-Mileo, Laura; Prat, Aleix; Mellado, Begona
CANCERS
(2021)
DOI /
10.3390/cancers13194960
Green published, Gold
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Letter
New anti-HER2 agents for brain metastasis: histology-agnostic weapons?
Tarantino, Paolo; Prat, Aleix; Curigliano, Giuseppe
BREAST CANCER RESEARCH AND TREATMENT
0167-6806 (2020)
DOI /
10.1007/s10549-020-05982-y
